Sign in
TerminatedNo phase

Biventricular Versus Right Ventricular Pacing

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Status
Terminated
People taking part
1 person enrolled
Started
9 Aug 2023
Ended
10 Nov 2023
Type of study
Interventional, 2 groups
Treatments tested
  • Biventricular Pacing
  • Right Ventricular Pacing
Record updated
10 December 2024
Why it stopped
Coordinator support was lost

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients with both an LVAD and CRT device with functional leads
  • Age 18 years and older
  • Ability to walk
  • Ability to sign consent

Who cannot take part

  • Patients with permanent atrial fibrillation
  • Patients who are pacemaker dependent
  • Patients with sustained ventricular tachycardia

Where in United States

  • Indiana University Health Methodist HospitalIndianapolis, United States

About the trial

What the trial wants to find out

The study is a randomized, single-blind crossover prospective study in which investigators will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing modalities in patients with left ventricular assist devices (LVAD). Only patients are blinded. This is a small-scale study from which future larger scale randomized controls can be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the 6-minute walk test.

The 2 groups in the trial

  • Biventricular Pacing followed by Right Ventricular PacingTreatment being tested

    Subjects will be randomly assigned to the order of pacing interventions. After baseline testing (with their CRT device still in the subjects' baseline pacing modality), subjects assigned to BiV-first will have their CRT device reprogrammed to BiV pacing modality in the clinic. After undergoing three months of treatment in this pacing modality, they will return to clinic for retesting. The CRT device will then be reprogrammed to RV pacing for the next 3 months. Subjects will then again return to clinic for retesting, and their CRT device will be reprogrammed to their baseline pacing modality.

    Treatment: Biventricular Pacing and Right Ventricular Pacing

  • Right Ventricular Pacing followed by Biventricular PacingTreatment being tested

    Subjects will be randomly assigned to the order of pacing interventions. After baseline testing (with their CRT device still in the subjects' baseline pacing modality), subjects assigned to RV-first will have their CRT device reprogrammed to RV pacing modality in the clinic. After undergoing three months of treatment in this pacing modality, they will return to clinic for retesting. The CRT device will then be reprogrammed to BiV pacing for the next 3 months. Subjects will then again return to clinic for retesting, and their CRT device will be reprogrammed to their baseline pacing modality.

    Treatment: Biventricular Pacing

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Selection of Cardiac Resynchronization Therapy Pacing Modalities in Patients Supported by LVADs
Record updated
10 December 2024